GDOCGoldman Sachs Future Health Care Equity ETF
Seeks long-term growth of capital.
By Goldman Sachs · Launched 2021
Annual Cost
0.75%
#3,918 of 5,854 · average
Fund Size
$19M
#4,501 of 5,854 · small
Return (1Y)Goal
+14.2%
Track Record
4 years
#2,480 of 5,854 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$11,619+16.2%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Multi cap
Strategy
Active selection
Sector
Health careFocus
General Innovation
What it actually holds
By weightConcentration
Top 10 holdings = 58.5% of fundmoderately concentrated
Eli Lilly & Co.
12.2%
Johnson & Johnson
8.1%
AstraZeneca PLC
6.4%
Merck & Co., Inc
6.0%
Boston Scientific Corporation
5.8%
Thermo Fisher Scientific Inc
4.6%
Intuitive Surgical Inc.
4.5%
Guardant Health Inc
3.7%
HOYA Corp.
3.6%
Argenx SE
3.6%
Asset allocation
Stocks
98.8%
Cash
1.2%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
16.2%Moderate
Year-on-year price swings
Max drawdown
-31.0%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.02Below average
Sortino (3Y)
0.03Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks long-term growth of capital.
- Strategy
- Actively manages a portfolio primarily invested in equity investments in U.S. and non-U.S. health care companies, focusing on small- and mid-capitalization firms. The Fund is not an index fund and measures performance against the MSCI ACWI Health Care Index.
- Inception date
- November 9, 2021
- Fund family
- Goldman Sachs
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at GDOC. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-03